Lenington Rachel — SEC Form 4 filings

SEC reporting owner CIK 1861194. 3 Form 4 filings on record with FilingPulse; latest filed 2024-09-05.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-02-16 to 2024-09-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Athira Pharma, Inc. (ATHA)COO and CDO32 legs · 4,937 sh · $8,4483

Form 4 filings — Lenington Rachel

FiledFormIssuerReported transactionsSource
2024-09-054Athira Pharma, Inc. (ATHA)Grant/award (A): 10,000 @ $0 · Sale (S): 2,525 @ $0.57EDGAR
2024-02-164/AAthira Pharma, Inc. (ATHA)Grant/award (A): 10,000 @ $0 · Sale (S): 2,412 @ $2.91EDGAR
2024-02-164Athira Pharma, Inc. (ATHA)Grant/award (A): 300,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1861194 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →